ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 330 out of 1206

$340K Total Retail Price of All Prescriptions

Rank: 389 out of 1206

313 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 313 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 313 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 429 395 1 3
FUROSEMIDE 390 375 2 5
LISINOPRIL 302 274 3 4
SIMVASTATIN 264 250 4 1
LEVOTHYROXINE SODIUM 239 232 5 2
POTASSIUM CHLORIDE 220 215 6 12
HYDROCODONE-ACETAMINOPHEN 206 179 S3 7 7
WARFARIN SODIUM 182 172 8 8
CITALOPRAM HBR 179 150 9 16
AMLODIPINE BESYLATE 166 131 10 6
ATENOLOL 157 142 11 14
FLUTICASONE PROPIONATE 145 136 12 42
PRAVASTATIN SODIUM 145 134 12 21
POLYETHYLENE GLYCOL 3350 136 134 14 31
METOPROLOL SUCCINATE 131 115 15 15
ALLOPURINOL 125 113 16 24
METOPROLOL TARTRATE 114 111 17 9
LOSARTAN POTASSIUM 105 91 18 20
METFORMIN HCL 100 91 19 10
PAROXETINE HCL 96 83 20 53
TRAZODONE HCL 92 87 21 37
ALENDRONATE SODIUM 92 92 21 19
RISPERIDONE 88 77 23 74
MIRTAZAPINE 88 88 23 50
SERTRALINE HCL 86 79 25 22
CRESTOR 86 53 25 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 69 27 27
RANITIDINE HCL 79 59 28 23
FLUOXETINE HCL 79 68 28 52
ISOSORBIDE MONONITRATE ER 78 78 30 40
METFORMIN HCL ER 77 59 31 58
CHLORTHALIDONE 76 69 32 118
PREDNISONE 69 58 33 28
GABAPENTIN 67 62 34 18
SPIRONOLACTONE 67 54 34 41
DOXAZOSIN MESYLATE 60 60 36 75
CARBIDOPA-LEVODOPA 60 60 36 70
AMITRIPTYLINE HCL 58 52 R 38 59
OXYBUTYNIN CHLORIDE 55 50 39 68
TAMSULOSIN HCL 53 51 40 26
ZOLPIDEM TARTRATE 50 48 41 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.